Cargando…

嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189478/
https://www.ncbi.nlm.nih.gov/pubmed/35680637
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.04.015
_version_ 1784725599663685632
collection PubMed
description
format Online
Article
Text
id pubmed-9189478
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-91894782022-06-14 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展 Zhonghua Xue Ye Xue Za Zhi 综述 Editorial office of Chinese Journal of Hematology 2022-04 /pmc/articles/PMC9189478/ /pubmed/35680637 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.04.015 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 综述
嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title_full 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title_fullStr 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title_full_unstemmed 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title_short 嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
title_sort 嵌合抗原受体t细胞免疫治疗t细胞恶性肿瘤研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189478/
https://www.ncbi.nlm.nih.gov/pubmed/35680637
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.04.015
work_keys_str_mv AT qiànhékàngyuánshòutǐtxìbāomiǎnyìzhìliáotxìbāoèxìngzhǒngliúyánjiūjìnzhǎn
AT qiànhékàngyuánshòutǐtxìbāomiǎnyìzhìliáotxìbāoèxìngzhǒngliúyánjiūjìnzhǎn